Hepatocellular carcinoma progression promoted by 5-lipoxygenase activity in CD163(+) tumor-associated macrophages.

[1]  Jibiao Wu,et al.  New insights from the single-cell level: Tumor associated macrophages heterogeneity and personalized therapy. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[2]  B. Baradaran,et al.  The cross-talk between tumor-associated macrophages and tumor endothelium: Recent advances in macrophage-based cancer immunotherapy , 2022, Biomedicine & Pharmacotherapy.

[3]  Yuli Lin,et al.  CAFs shape myeloid‐derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5‐lipoxygenase , 2021, Hepatology.

[4]  O. Demidov,et al.  Lactobacillus stress protein GroEL prevents colonic inflammation , 2021, Journal of Gastroenterology.

[5]  Marimuthu Citartan,et al.  Evaluating the Polarization of Tumor-Associated Macrophages Into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical Practice , 2020, Frontiers in Oncology.

[6]  A. Villanueva.  Hepatocellular Carcinoma. , 2019, The New England journal of medicine.

[7]  N. Mukaida,et al.  Alveolar Macrophages Drive Hepatocellular Carcinoma Lung Metastasis by Generating Leukotriene B4 , 2018, The Journal of Immunology.

[8]  D. Steinhilber,et al.  Apoptotic Cancer Cells Suppress 5-Lipoxygenase in Tumor-Associated Macrophages , 2018, The Journal of Immunology.

[9]  O. Werz,et al.  Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity , 2018, Nature Communications.

[10]  Yong-Jiang Xu,et al.  Metabolomics and eicosanoid analysis identified serum biomarkers for distinguishing hepatocellular carcinoma from hepatitis B virus-related cirrhosis , 2017, Oncotarget.

[11]  Jeffrey W Pollard,et al.  Tumor-associated macrophages: from mechanisms to therapy. , 2014, Immunity.

[12]  J. Kim,et al.  A leukotriene B4 receptor-2 is associated with paclitaxel resistance in MCF-7/DOX breast cancer cells , 2013, British Journal of Cancer.

[13]  Y. Kanai,et al.  Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer , 2013, British Journal of Cancer.

[14]  Ximing Xu,et al.  5-Lipoxygenase contributes to the progression of hepatocellular carcinoma. , 2011, Molecular medicine reports.

[15]  Dongmei Guo,et al.  Circulating LTD4 in patients with hepatocellular carcinoma , 2011, Tumor Biology.

[16]  S. Cuzzocrea,et al.  The 5‐lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages , 2010, British journal of pharmacology.

[17]  R. DuBois,et al.  Eicosanoids and cancer , 2010, Nature Reviews Cancer.

[18]  E.Y. Kim,et al.  Ras-induced invasion and metastasis are regulated by a leukotriene B4 receptor BLT2-linked pathway , 2010, Oncogene.

[19]  W. Henderson,et al.  Mechanisms of disease: Leukotrienes , 2007 .

[20]  Hirokazu Takahashi,et al.  Blockade of leukotriene B4 signaling pathway induces apoptosis and suppresses cell proliferation in colon cancer. , 2007, Journal of Pharmacological Sciences.

[21]  T. Adrian,et al.  LTB4 stimulates growth of human pancreatic cancer cells via MAPK and PI-3 kinase pathways. , 2005, Biochemical and biophysical research communications.

[22]  D. Beer,et al.  Overexpression of 5-Lipoxygenase in Rat and Human Esophageal Adenocarcinoma and Inhibitory Effects of Zileuton and Celecoxib on Carcinogenesis , 2004, Clinical Cancer Research.

[23]  G. Landberg,et al.  Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas. , 2003, Gastroenterology.

[24]  H. Friess,et al.  5-Lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue. , 2002, The American journal of pathology.

[25]  D. Bostwick,et al.  Lipoxygenase‐5 is overexpressed in prostate adenocarcinoma , 2001, Cancer.

[26]  A. Sjölander,et al.  Leukotrienes induce cell-survival signaling in intestinal epithelial cells. , 2000, Gastroenterology.